Which of the following is classified as intermediate acting insulin?

Intermediate-acting insulin is designed to cover insulin needs for a longer duration compared to rapid-acting insulins while not lasting as long as long-acting ones. NPH (Neutral Protamine Hagedorn) is a protamine-modified form of regular insulin, which gives it a delayed onset and longer duration of action. NPH typically has its onset of action within 1 to 2 hours, peaking at around 4 to 6 hours, and lasting up to 10 to 16 hours, making it suitable for patients who require coverage during the day or night.

Lente is another form of intermediate-acting insulin, which also provides a similar duration of action. This classification is essential for managing diabetes as it helps to imitate the body's natural insulin release, allowing for better glycemic control throughout the day.

Understanding the classifications of insulin is crucial for effective diabetes management, as it helps healthcare professionals prescribe the appropriate insulin regimen based on a patient's needs. This knowledge allows for the adjustment of dosage and timing in relation to meals and activities throughout the day.